Gossamer Bio secures option to acquire Respira Therapeutics
PositiveFinancial Markets

Gossamer Bio has successfully secured an option to acquire Respira Therapeutics, a move that could significantly enhance its portfolio in the respiratory treatment space. This acquisition is important as it reflects Gossamer's commitment to expanding its capabilities and addressing unmet medical needs in respiratory diseases, potentially leading to innovative therapies for patients.
— Curated by the World Pulse Now AI Editorial System